COVID-19 Vaccine Patent Infringement? The Battle Between Moderna and Pfizer/BioNTech Continues
Bill of Health
JANUARY 12, 2023
2010/144740 and in the 966 patent. More broadly, BioNTech and Pfizer highlight Moderna’s surreptitious conduct of obtaining its mRNA patents without disclosing the government’s role in its funding and development. Indeed, as made public, the U.S. Moderna has since made over $30 billion in COVID-19 vaccine sales.
Let's personalize your content